By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Boston Therapeutics, Inc. 

1750 Elm Street, Suite 103

Manchester  New Hampshire  03104  U.S.A.
Phone: 603-935-9799 Fax: 603-685-4784


SEARCH JOBS


Industry
Pharmaceutical






Company News
Boston Therapeutics, Inc. ' Hong Kong Affiliate Receives Department Of Health Certificate To Initiate SUGARDOWN(R) Clinical Trial 1/28/2015 12:29:51 PM
Boston Therapeutics, Inc. ' sugardown® Significantly Reduces Glucose, Fructose And Insulin Levels In Sugary Soft Drinks 1/20/2015 11:26:14 AM
Boston Therapeutics, Inc. To Present At 8th Annual OneMedForum Conference In San Francisco 1/8/2015 2:21:58 PM
Boston Therapeutics, Inc. ' sugardown® Shown To Reduce Glucose Levels Following Consumption Of Sugary Beverages 1/6/2015 10:44:39 AM
Boston Therapeutics, Inc. Announces FDA Acceptance Of IND To Initiate A Clinical Trial Of BTI-320 To Treat Type ll Diabetes And Weight Loss 12/11/2014 8:14:14 AM
Boston Therapeutics, Inc. and Advance Pharmaceutical Expand Agreement To Market Sugardown® In 12 Additional Countries In Asia 11/24/2014 9:48:37 AM
Boston Therapeutics, Inc. Initiates Clinical Study At Sydney University To Evaluate sSugardown® With Sugary Beverage Consumption 11/19/2014 12:57:52 PM
Boston Therapeutics, Inc. Reports Third Quarter Results And Provides Corporate Update 11/10/2014 10:50:05 AM
Boston Therapeutics, Inc. Announces The North America Branding Of Sugardown®: A New Natural Product That Helps Maintain Healthy Blood Sugar Levels 11/4/2014 1:08:22 PM
Boston Therapeutics, Inc. Reports Topline U.S.-Based Phase 2b Study Results Of BTI-320 In Patients With Type 2 Diabetes 10/9/2014 8:01:18 AM
12345678
//-->